Dog Benign Prostatic Hyperplasia: Welfare and Neutering

Benign prostatic hyperplasia is a common condition in entire male dogs that causes discomfort and complications, largely resolved by castration.

Key Facts

BPH affects up to 80% of intact male dogs over 5 years; testosterone drives progressive prostatic enlargement.
Clinical signs include constipation, dysuria, blood-tinged urethral discharge, and reluctance to defecate.
Castration resolves BPH completely in 90% of cases within 4-6 weeks as the prostate involutes.
Prostatic cysts, abscesses, and squamous metaplasia are complications that require specific surgical or medical management.
Medical options including osaterone acetate (Ypozane) temporarily shrink the prostate without surgical castration.
Intact male dogs used for breeding should be monitored regularly for BPH signs from 5 years onwards.

Welfare Considerations

BPH causes chronic discomfort through physical compression of the rectum and urethra. Constipation and difficult urination cause daily welfare compromise in affected dogs. Castration is a simple, definitive solution that dramatically improves welfare. Owners who resist castration for intact working or breeding dogs should commit to monitoring and medical management to prevent suffering. Prostate cancer, though uncommon, can mimic BPH — biopsy is indicated for atypical or non-responsive cases.

What You Can Do

Monitor intact male dogs over 5 years for signs of prostatic enlargement — straining to defecate is a key indicator.
Discuss castration with your vet as the definitive welfare solution for BPH.
If castration is declined, discuss medical management with osaterone acetate to reduce prostate size.
Annual rectal palpation of the prostate is recommended for intact males over 5 years.